Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer. | Cell Rep | 2023 | 37453058 | PubTator, text mining | PubMed |
| Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents. | Molecules | 2023 | 37446626 | PubTator, text mining | PubMed |
| Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases. | Int J Mol Sci | 2023 | 37446377 | PubTator, text mining | PubMed |
Extensive Bioinformatics Analyses Reveal a Phylogenetically Conserved Winged Helix (WH) Domain (Zτ) of Topoisomerase IIα, Elucidating Its Very High Affinity for Left-Handed Z-DNA and Suggesting Novel Putative Functions. | Int J Mol Sci | 2023 | 37445918 | PubTator, text mining | PubMed |
| Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. | Clin Cancer Res | 2023 | 37439680 | PubTator, text mining | PubMed |
| Molecular Glue Discovery: Current and Future Approaches. | J Med Chem | 2023 | 37437222 | PubTator, text mining | PubMed |
| Using energy to go downhill - a genoprotective role for ATPase activity in DNA topoisomerase II. | bioRxiv | 2023 | 37425896 | PubTator, text mining | PubMed |
| CTCF and Its Multi-Partner Network for Chromatin Regulation. | Cells | 2023 | 37408191 | PubTator, text mining | PubMed |
| Naturally mutagenic sequence diversity in a human type II topoisomerase. | Proc Natl Acad Sci U S A | 2023 | 37406101 | PubTator, text mining | PubMed |
| How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations. | JACC CardioOncol | 2023 | 37397077 | PubTator, text mining | PubMed |
| Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways. | Cell Death Discov | 2023 | 37393350 | PubTator, text mining | PubMed |
| Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals. | J Alzheimers Dis | 2023 | 37334609 | PubTator, text mining | PubMed |
| LRRC8A promotes the initial development of oxaliplatin resistance in colon cancer cells. | Heliyon | 2023 | 37313175 | PubTator, text mining | PubMed |
| Polyamine-Drug Conjugates: Do They Boost Drug Activity? | Molecules | 2023 | 37298993 | PubTator, text mining | PubMed |
| Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology. | Cancers (Basel) | 2023 | 37297017 | PubTator, text mining | PubMed |
| Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies. | Diagnostics (Basel) | 2023 | 37296716 | PubTator, text mining | PubMed |
| Inborn errors of human B cell development, differentiation, and function. | J Exp Med | 2023 | 37273190 | PubTator, text mining | PubMed |
| Synthesis, Characterization, and Biological Evaluation of Meldrum's Acid Derivatives: Dual Activity and Molecular Docking Study. | Pharmaceuticals (Basel) | 2023 | 37259425 | PubTator, text mining | PubMed |
| Phosphorylation status of MUS81 is a modifier of Olaparib sensitivity in BRCA2-deficient cells. | Nucleic Acids Res | 2023 | 37254810 | PubTator, text mining | PubMed |
| DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence. | Retrovirology | 2023 | 37254203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=12